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Edited by Roberto SitiaAbstract Redox imbalance in the endoplasmic reticulum lumen
is the most frequent cause of endoplasmic reticulum stress and
consequent apoptosis. The mechanism involves the impairment
of oxidative protein folding, the accumulation of unfolded/mis-
folded proteins in the lumen and the initiation of the unfolded
protein response. The participation of several redox systems
(glutathione, ascorbate, FAD, tocopherol, vitamin K) has been
demonstrated in the process. Recent ﬁndings have attracted
attention to the possible mechanistic role of luminal pyridine
nucleotides in the endoplasmic reticulum stress. The aim of this
minireview is to summarize the luminal redox systems and the re-
dox sensing mechanisms of the endoplasmic reticulum.
 2007 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
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Decades after its formulation, Hans Selye’s stress theory [1]
triumphantly descended to the subcellular level. In the original
context, animal life exists by maintaining a complex dynamic
equilibrium, termed homeostasis that is constantly challenged
by intrinsic or extrinsic adverse forces, the stressors. Stress is
deﬁned as a state of threat, or perceived threat to homeostasis.
Imbalance of homeostasis at the cellular level can be sensed by
various organelles. The stress-sensing capability of mitochon-Abbreviations: ATF6, activating transcription factor 6; BiP, immuno-
globulin heavy chain-binding protein; DHAR, dehydroascorbate
reductase; ER, endoplasmic reticulum; Ero1, endoplasmic reticulum
oxidoreductin 1; ERp44 and 57, endoplasmic reticulum protein of
molecular weight 44 or 57 kDa; GRP78, glucose-regulated protein of
molecular weight 78 kDa; G6PT, glucose-6-phosphate transporter;
H6PDH, hexose-6-phosphate dehydrogenase; 11bHSD1, 11b-
hydroxysteroid dehydrogenase type 1; InsP3R, inositol 1,4,5-trisphos-
phate receptor; IRE1, inositol-requiring enzyme 1; PDI, protein
disulﬁde isomerase; PERK/PEK, PKR-like ER protein kinase/pancre-
atic eIF2a (eukaryotic translation initiation factor 2, a subunit) kinase;
SERCA, sarco/endoplasmic reticulum Ca2+-ATPase; UPR, unfolded
protein response
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doi:10.1016/j.febslet.2007.04.028dria, lysosomes and the constituents of the secretory pathway
including the endoplasmic reticulum (ER) and the Golgi-appa-
ratus has been described [2–5]. In particular, ER stress has
been in the focus of increased attention in the last years (for
recent reviews see [6–9]). The role of the ER as a sensor for
electron donors and acceptors, i.e. nutrients and oxygen, is a
recent suggestion. Diverse nocuous agents can aﬀect adversely
the proper functioning of the ER, causing the typical syn-
drome of the ER stress, the signs of which are independent
of the nature of either the damaging agent or the pharmacolog-
ical type of the drug employed. Most of these agents disturb
the redox homeostasis of the ER lumen, which is subsequently
detected by local sensors resulting in the activation of ER-to-
nucleus signalling pathways.2. Redox environment in the ER lumen
The major redox couples participating in the electron transfer
processes of the cell are also present in the ER lumen, although
concentrations and redox states can diﬀer between the two com-
partments. Redox state refers to the ratio of the interconvertible
oxidized and reduced forms of a speciﬁc redox couple. This term
is also used in amore general sense not only for deﬁning the state
of a particular redox pair, but for describing the entire redox
environment of a subcellular compartment. The term redox
environment most accurately deﬁnes the redox characteristics
of a certain organelle, as a sum of redox potentials and reducing
capacities of linked redox couples present [10].
However, it is impossible to determine the redox environ-
ment by the measurement of all linked redox couples. Instead,
the changes in the redox environment are monitored using a
representative redox couple as an indicator. In the animal cell,
the abundant glutathione disulﬁde (GSSG) /reduced glutathi-
one (GSH) couple provides a very large pool of redox compe-
tent molecules, hence it is considered to be the major cellular
redox buﬀer. Therefore, the redox state of this couple can be
used as an indicator for the redox environment of the cell or
a subcellular compartment.
Local oxidoreductions, transmembrane transport of extralu-
minally synthesized redox-active compounds and transmem-
brane electron ﬂuxes lay down the redox environment of the
ER lumen. Similarly to other compartments of the cell, the
major redox buﬀer of the lumen is the GSSG/GSH couple.
Although the ER luminal and cytosolic glutathione concentra-
tions are similar (i.e. 1–10 mM), the ratio of [GSSG] to [GSH]blished by Elsevier B.V. All rights reserved.
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ranges of approximately 1:1–3 versus 1:30–100, respectively
[11,12]. These ratios result in redox potentials of about
180 mV and 230 mV, respectively, i.e. the ER lumen can
be regarded as a more oxidizing environment. Moreover, high
percentage of luminal glutathione was shown to form mixed
disulﬁdes with proteins, which may play a role as a GSH re-
serve and also as a component of the thiol-disulﬁde redox buf-
fering system [13].
It was supposed that this peculiar intraluminal ER milieu en-
sures disulﬁde bond formation in secretory proteins by main-
taining an oxidizing power. However, it has been shown that
protein disulﬁde formation is independent of glutathione, both
under in vivo and in vitro conditions [14,15]. The process is cat-
alyzed by a protein-mediated electron relay system, in which
protein disulﬁde isomerase [16] and Ero1p [17–20] are the main
players and oxygen is the ultimate electron acceptor. These
studies demonstrated that, contrary to previous assumptions,
glutathione is not the source of oxidizing equivalents for oxi-
dative protein folding within the ER. Instead, it functions as
a reductant for both protein disulﬁde isomerase (PDI) and
secretory proteins, allowing the isomerization of disulﬁde
bonds, until the correct conformation is achieved. Another
important conclusion of these recent ﬁndings is that the pro-
oxidant environment within the ER is not the actual cause,
but rather the consequence of the oxidative protein folding.
Nevertheless, the possible interferences between the GSSG/
GSH system and both oxidation and reduction of protein thi-
ols underscores the importance of a tight regulation of the ER
redox milieu, since changes in either direction drastically inter-
fere with ER functions.
Beside glutathione, the other antioxidant components of the
Halliwell-Asada cycle are also present in the ER. The cycle
may represent an alternative (minor?) pathway for the transfer
of electrons from protein thiols to oxygen. Ascorbate acts not
only as an antioxidant in the lumen, but also as a cofactor forFig. 1. The best known redox systems in the ER. For simplicity, only one me
from the left to the right. The grey bar symbolizes the redox potential of the E
concentrations: 0.18 V. Abbreviations: DHAR, dehydroascorbate reduc
hydroxysteroid dehydrogenase type 1; PDI, protein disulﬁde isomerase.various luminal enzymes (e.g. prolyl- and lysyl-hydroxylases)
and its oxidized form, dehydroascorbate can accept electrons
from protein disulﬁde isomerase [21–23]. Ascorbate, in turn,
can regenerate the oxidized form of tocopherol, a hydrophobic
antioxidant in the ER membrane, which can mediate a trans-
membrane electron transfer [24]. Ascorbate is formed in the
ER of ascorbate-synthesizing animals, while in species unable
to produce this vitamin it is transported through the mem-
brane as dehydroascorbic acid [22]. This circumstance might
cause – presently unexplored – diﬀerences in the ascorbate-
dependent processes of the ER.
The presence of other redox-active compounds has also been
demonstrated. c-Carboxylation of vitamin K-dependent pro-
teins in the ER involves the formation of reduced vitamin K,
an essential cofactor for c-carboxylase catalyzing this post-
translational protein modiﬁcation. By accepting electrons from
protein disulﬁde isomerase, vitamin K can be regenerated dur-
ing the protein c-carboxylation-linked redox cycle [25]. FAD is
known to act both as a tightly associated prosthetic group and
as a relatively free cofactor of Ero1, therefore making this en-
zyme highly responsive to small changes in the physiological
levels of free FAD [15,26]. Although FAD transport has been
demonstrated in yeast and rat liver microsomes, the concentra-
tion and redox state of luminal FAD are unknown.
Most of these redox couples are linked to each other to form
complex redox systems (Fig. 1). In some cases, couples are
independent from each other if they are not linked by appro-
priate enzyme systems and the activation energies of the elec-
tron transfer reactions are high. For example, the luminal
pyridine nucleotide pool and the GSH/GSSG system seem to
be uncoupled. Although their in vivo redox state and concen-
trations have not been elucidated, pyridine nucleotides must
be present in the ER lumen, since several oxidoreductases with
intraluminal active site require them as coenzymes. In fact,
ER-derived microsomal vesicles contain a signiﬁcant amount
of pyridine nucleotides [27]. This pool is overwhelminglymber of each redox couple is indicated. Redox potentials are increasing
R lumen calculated on the basis of glutathione and glutathione disulﬁde
tase; H6PDH, hexose-6-phosphate dehydrogenase; 11bHSD1, 11b-
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the in vivo situation. This assumption is supported by observa-
tions concerning the functioning of the ER enzyme 11b-
hydroxysteroid dehydrogenase type 1 (11bHSD1). 11bHSD1
catalyzes the reversible interconversion of cortisone and corti-
sol in the lumen of the ER [28]. Under in vivo conditions this
reaction is predominantly shifted towards cortisone reduction,
indicating a high luminal [NADPH]/[NADP+] ratio. The high
ratio can be maintained by luminal dehydrogenases, such as
hexose-6-phosphate dehydrogenase (H6PDH), because the
permeability of the ER membrane to pyridine nucleotides is
insigniﬁcant [29]. H6PDH knockout mice lack 11bHSD1 med-
iated glucocorticoid generation [30], which proves that the en-
zyme cannot rely on cytosolic NADPH resources and that a
separate luminal pyridine nucleotide pool must exist [31,32].
It also clearly shows that the high luminal [NADPH]/[NADP+]
ratio is dependent on the H6PDH activity and – consequently –
on the transport of the substrate glucose-6-phosphate across
the ER membrane [33].
In the cytosol, both NADPH and glutathione are present
predominantly in the reduced state due to the enzymatic cou-
pling of the two redox couples, glutathione disulﬁde being re-
duced at the expense of NADPH in a reaction catalyzed by
glutathione reductase. In spite of the oxidizing power of the
GSSH/GSH system, pyridine nucleotides remain reduced in
the ER lumen. The peaceful coexistence of the two redox sys-
tems is ensured by their uncoupling, since glutathione reduc-
tase is hardly detectable in the lumen [32].3. Transport of redox-active compounds in the ER
The ER is an island surrounded by a sea of cytosol. Not sur-
prisingly, redox-active compounds coming from or leaving to-
wards the cytosol can profoundly aﬀect the environment in the
ER lumen. Although the permeation of several redox-active
compounds has been explored in the ER membrane (Fig. 2),Fig. 2. Permeability and entrapment: determinants of luminal redox. Uppe
acceptors. Translocon channel (and presumably other less identiﬁed pores in
low-capacity transport of various small molecules. With the exception of trans
been characterized functionally. Abbreviations: AA, ascorbate; DAA, dehydro
glucose-6-phosphate; 6PGate, 6-phosphogluconate; G6PT, glucose-6-phosphidentiﬁcation of the proteins participating in these transport
processes lags behind. In comparison with other organelles,
limited knowledge is available with regard to ER transporters,
due to the technical diﬃculty of ER transport measurements
and of the puriﬁcation and reconstruction approach [34].
The majority of reducing equivalents are transported into
the lumen through the translocon protein channel as cysteinyl
thiols of the newly synthesized secretory proteins. An open
translocon can mediate the transport of small molecules; its
participation in the permeation of redox-active compounds
cannot be excluded [35]. GSH has a slow protein-mediated
transport, while the membrane is impermeable to GSSG [36].
This observation rules out the previous hypothesis [12] that
the high [GSSG]/[GSH] ratio can be obtained through prefer-
ential import of GSSG from the cytosol. On the contrary, the
locally oxidized GSH is entrapped in the form of GSSG in the
lumen, contributing to the maintenance of the oxidizing envi-
ronment in the compartment.
Reducing equivalents are transported into the lumen also in
the form of glucose-6-phosphate. The corresponding trans-
porter (G6PT) is one of the few ER transporters characterized
at the molecular level [33]. The transport and the coupled
H6PDH activity seem to be mainly responsible for the mainte-
nance of the reduced state of the luminal pyridine nucleotide
pool [29,32].
Although luminal oxidoreductases contribute dominantly to
the oxidative environment, transport of oxidants is also impor-
tant. The transport of dehydroascorbate and FAD has been
evidenced in the ER [26,37,38]. Both compounds facilitate
luminal thiol oxidation [21,22,26,38], therefore the physiologi-
cal role of their transport has been proposed. The ER
membrane is selectively permeable to dehydroascorbate, the
oxidized form of ascorbate [37]. Luminal reduction of dehy-
droascorbate to ascorbate is associated with thiol oxidation
and leads to an ascorbate entrapment [22]. FAD uptake and
consequent thiol oxidation have also been found in yeast and
liver microsomes [26,38]. In contrast to FAD, pyridine nucleo-r side: transport of electron donors; lower side: transport of electron
the ER membrane) can be responsible for the non-speciﬁc, low-aﬃnity
locon and G6PT, other redox-competent transport processes have only
ascorbate; Col, cortisol; Cone, cortisone, TL, translocon channel; G6P,
ate translocase.
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a signiﬁcant rate, which is indicated by the high latency of
luminal H6PDH and 11bHSD1 [31] and by direct transport
measurements [32].4. BiP-mediated redox sensing
Formation of disulﬁde bonds in proper positions is required
for the folding of the majority of secretory and membrane pro-
teins. Redox imbalance caused by either experimental agents
or pathophysiological conditions leads to the accumulation
of unfolded/misfolded proteins in the ER lumen. Either oxida-
tive or reductive stress can pose a similar danger as implicated
by the ER stress component involved in the putative patho-
mechanism of ageing, Alzheimer, diabetes, etc. (for review
see [8,9]). The accumulation of defective proteins can lead to
the activation of a coordinated adaptive program through
ER-to-nucleus signalling, called the unfolded protein response
(UPR) [6]. In response to the accumulation of unfolded pro-
teins in the ER, the rate of general translation initiation is
attenuated, ER resident chaperones and foldases are induced
and the ER membrane proliferates to enlarge the luminal com-
partment, also ER-associated degradation is activated to elim-
inate the misfolded proteins. Finally, if prosurvival eﬀorts are
exhausted, ER-stress related apoptosis is activated. The pres-
ent theory of the UPR premises that the various misfolded
proteins are recognized and the diverse signalling pathways
are initiated by a single master regulator, BiP.
Nascent unfolded polypeptides are maintained in soluble
form by interactions with ER luminal chaperones in stress-free
conditions. BiP (immunoglobulin heavy chain-binding protein
or GRP78, glucose-regulated protein of molecular weight
78 kDa) is one of the most abundant ER resident chaperones.
To date there are three identiﬁed proximal sensors of the UPR:
the PKR-like ER protein kinase/pancreatic eIF2a (eukaryotic
translation initiation factor 2, a subunit) kinase (PERK/PEK);
the activating transcription factor 6 (ATF6); and the inositol-
requiring enzyme 1 (IRE1). These sensors are integral proteins
of the ER membrane; the association of their luminal domain
with BiP keeps them in inactive state. According to the current
model of UPR, the perturbed ER homeostasis leads to the
accumulation of unfolded/misfolded proteins in the ER lumen,
which can preferentially bind BiP sequestering the chaperon in
the lumen. The consequent dissociation of BiP from the trans-
membrane sensors permits their signalling [6]. This hypothesis
is supported by the fact that BiP is found in association with
the stress transducers under stress-free conditions and is re-
leased upon accumulation of unfolded proteins. Moreover,
overexpression of BiP attenuates UPR through all the three
branches of signalling. In conclusion, BiP functions as an un-
folded protein sensor to mechanistically link luminal redox
imbalance with UPR activation. This attractive model, though
valid in case of experimental, acute and severe ER stress, can-
not account for the selective activation of ER stress sub-path-
ways in pathophysiological conditions. Therefore, the in vivo
mechanism seems much more complicated than previously
thought. The passive competition model for BiP between un-
folded proteins and transmembrane signal transducers has
been challenged by recent observations. A relatively stable
binding between ATF6 and BiP was observed, and a regionwithin the ATF6 luminal domain was identiﬁed as a speciﬁc
ER stress-responsive sequence required for ER stress-triggered
BiP release [39]. Furthermore, deletion of the BiP-binding site
of IRE1 failed to alter the inducibility of ER stress, showing
that BiP is not the principal determinant of IRE1 activity,
but an adjustor for sensitivity to various stresses [40]. On the
basis of these ﬁndings it can be supposed that other regulators
are also involved in the response initiation, or that other tissue-
speciﬁc adaptor proteins can ensure the pleiotropic signalling
and biological responses upon the activation of UPR in re-
sponse to diﬀerent physiological stimuli.5. Direct redox sensing
Changes in the luminal redox state can be sensed not only by
secretory proteins that await folding, but also directly by trans-
membrane proteins involved in signalling. For example, in case
of ATF6 the complex formation/dissociation with BiP is not
the only regulatory mechanism. It has been recently shown
that owing to the presence of intra- and intermolecular disul-
ﬁde bridges, ATF6 is present in unstressed ER in monomer, di-
mer or oligomer form. The disulﬁde bonds of ATF6 are
reduced upon treatment of cells with various experimental
ER stress inducers, which increase the amount of reduced
ATF6 monomers that are active in the UPR signalling. ER
stress evoked by more physiological mechanism, such as glu-
cose starvation, also activates ATF6. Beside an enhanced
ATF6 synthesis likely due to transcriptional induction, reduc-
tion of disulﬁde bridges and transport of reduced monomers to
Golgi occurred in response to glucose starvation. The results
show that at least two events are necessary for ATF6 activa-
tion, namely the dissociation of BiP and the reduction of disul-
ﬁde bridges [41,42]. Although the mechanism of ATF6
reduction is still enigmatic, it was supposed that ER luminal
oxidoreductases, activated upon glucose starvation, may par-
ticipate in the process. The enzymes responsible and the source
of luminal reducing power remain to be clariﬁed.
Ca2+ release from the luminal store is an important event of
ER stress and ER-dependent apoptosis. Several observations
stress the role of luminal redox changes in cellular calcium
homeostasis. Both ER/SR calcium channels and calcium
pumps can serve as subjects for intraluminal redox regulation.
Redox-sensitive thiols in the ryanodine receptor calcium chan-
nel are targets for oxidoreduction; the reactions modulate the
open probability of the channel. On this ground, the ryanodine
receptor calcium channel has been postulated as a transmem-
brane redox sensor in the SR [43,44]. Recent ﬁndings demon-
strate that the function of the InsP3 receptor (InsP3R) is also
governed by ER luminal redox status. It was found that
ERp44, an ER luminal protein belonging to the thioredoxin
family, directly interacts with the third luminal loop of InsP3R
type 1 (InsP3R1) and directly inhibits the receptor. This inter-
action is dependent on the redox state (as well as on luminal
pH and Ca2+ concentration). The presence of reduced cysteinyl
thiols in the third loop is required for the interaction. Thus,
ERp44 senses the environment in the ER lumen and modulates
the calcium homeostasis through IP3R1 activity [45].
Calcium reuptake into the ER is also regulated by the redox
state and calcium. The luminal protein ERp57 was shown
to regulate SERCA2b activity [46]. ERp57 overexpression
3638 G. Ba´nhegyi et al. / FEBS Letters 581 (2007) 3634–3640reduces the frequency of SERCA 2b-dependent Ca2+ oscilla-
tions; the eﬀect is dependent on the presence of cysteinyl resi-
dues located in intraluminal loop 4. Store depletion results in
ERp57 dissociation and a relief of SERCA2b inhibition. The
results suggest that ERp57 modulates the redox state of lumi-
nal thiols in SERCA 2b in a Ca2+-dependent manner, provid-
ing dynamic control of ER Ca2+ homeostasis.
These interactions between luminal redox and Ca2+ signal-
ling may also be signiﬁcant in the cellular response to stress,
serving to protect the cell from apoptosis. Indeed, expression
of both ERp57 and ERp44 is increased by cellular stress.
ERp44 overexpression was shown to inhibit apoptosis [45].
In conclusion, these studies underline the interdependence of
luminal redox state, oxidative protein folding and calcium sig-
nalling. InsP3R-induced calcium release may be an important
link between luminal redox imbalance and apoptosis.6. Beyond thiols
One can suppose that the imbalance of luminal redox sys-
tems other than the GSH/GSSG couple also initiates ER stress
response. Since the ascorbate/dehydroascorbate and FAD/
FADH2 couples are in intimate connection with the thiol/
disulﬁde systems, it is not surprising that riboﬂavin deﬁciency
in Jurkat or HepG2 cells [47,48] or ascorbate deﬁciency
(scurvy) in guinea pigs [49] triggers ER stress. These ﬁndings
underline the possible role of the corresponding transporters
in ER pathology.
However, the NAD(P)H/NAD(P)+ system is not connected
by a direct enzymatic route to the thiol/disulﬁde systems. Con-
sequently, alterations of the redox state of pyridine nucleotides
are not mirrored in the redox state of glutathione or secretory
proteins, therefore the ‘‘classic’’ UPR signalling pathways are
presumably not activated. However, several observations indi-
cate that conditions which can be linked to an altered redox
state of luminal pyridine nucleotides are associated with ER
stress.
The reduced state of luminal NADPH is maintained by the
concerted action of G6PT and of the luminal H6PDH [28,29].
A high [NADPH]/[NADP+] ratio is important not only for the
substrate supply of luminal reductases (including 11bHSD1),
but also because of the role NADPH plays as an antiapoptotic
factor. Indeed, inhibition or downregulation of G6PT results
in increased apoptosis in glioma cells [50,51] or neutrophil
granulocytes [52]. In line with these observations, inborn deﬁ-
ciency of G6PT in glycogen storage disease type 1b is charac-
terized by severe neutropenia and neutrophil dysfunction [53].
Although the in vivo redox state of the luminal NADPH/
NADP+ system is still unknown and there is no direct evidence
of it being changed under pathological conditions, it can be
hypothesized that the altered expression/activity of luminal
NADP(H)-dependent oxidoreductases is reﬂected by a redox
shift. For example, 11bHSD1 and H6PDH expression and
activity are changed in the experimental animal models of
obesity, metabolic syndrome and type 2 diabetes. These en-
zymes are mainly expressed in the liver and in adipose tissue.
In accordance with this assumption, obesity causes ER stress
in adipose and liver tissues of mouse models with either dietary
or genetic obesity. The stress, in turn, leads to the IRE1-depen-
dent activation of c-Jun N-terminal kinase and subsequent ser-
ine phosphorylation of insulin receptor substrate-1. Theseevents suppress insulin receptor signalling. Deﬁciency of the
Xbox-binding protein-1, a transcription factor that modulates
the ER stress response, leads to insulin resistance in mice [54].
These ﬁndings demonstrate that ER might be a sensor orga-
nelle for metabolic stress in obesity and the ER stress response
is an important component in the development of further met-
abolic consequences, such as insulin resistance and type 2
diabetes [55]. These observations are conﬁrmed by other inde-
pendent studies that have demonstrated the close connection
between ER function and insulin sensitivity [56,57]. If we
accept that ER stress has an important role in mediating insu-
lin resistance not only in animal models of obesity but also in
humans, pharmacological stimulation of folding capacity
might be a promising therapeutic approach. Chemical chaper-
ones – i.e. small molecules that can facilitate protein folding
and attenuate unfolded protein response activation – are
promising candidates in the treatment of insulin resistance
[58]. The eﬀectiveness of these agents has been already proved
in a mouse model of type 2 diabetes [59].
Since the ER is very sensitive to glucose, lipid, oxygen and
energy availability, it could be regarded as an essential and an-
cient site of integration between nutrients. However, the mech-
anism of this integration is poorly understood. The cytosolic
NADPH supply as an integrative tool of carbohydrate and
lipid metabolism has been known for a long while; it is tempt-
ing to suppose that similar mechanism can be operative in the
ER lumen. High glucose-6-phosphate supply through the acti-
vation of H6PDH and 11bHSD1 leads to increased cortisol
production. This event, prereceptorial glucocorticoid activa-
tion is supposed to be responsible for the majority of metabolic
changes seen in obesity, metabolic syndrome and type 2 diabe-
tes. In conclusion, sensing of metabolic alterations through the
altered activity of certain luminal oxidoreductases could
change the luminal redox state which leads to glucocorticoid
activation and autocrine signalling. This putative novel mech-
anism of ER stress response echoes Selye’s stress theory on a
subcellular level.7. Concluding remarks
ER stress is an important tool of the cell to cope with the
changes of both intra- and extracellular environment. ER
‘‘eustress’’ (i.e. a positive, desirable form of stress) and UPR
are indispensable for professional secretory cells, such as anti-
body-secreting plasma cells, collagen-secreting osteoblasts,
cells of endocrine and exocrine organs. In these cells physiolog-
ical ER stress serves as an accommodation process to the in-
creased demand to ensure proper function and survival. On
the other hand, chronic activation of the ER signalling path-
ways in ER ‘‘distress’’ is an emerging candidate as a crucial
factor in the pathomechanism of numerous civilization dis-
eases caused by longevity, lifestyle factors, high input of and
low demand for energy. Understanding the luminal redox
and mapping the pathways involved is essential for the devel-
opment of successful therapeutic strategies for the treatment of
ER-stress-related diseases.
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